Ketan Patil

Title: Innovations of Ketan Patil in Neurodegenerative Disease Research

Introduction

Ketan Patil is an accomplished inventor based in Queens, NY, with a focus on neurodegenerative diseases. He holds a total of seven patents that contribute significantly to the field of medical research, particularly in the diagnosis and prognosis of conditions such as Parkinson's and Alzheimer's diseases.

Latest Patents

Among his latest innovations, Ketan Patil has developed a patent for "Circulating serum microRNA biomarkers and methods for Parkinson's disease prognosis." This invention provides biomarkers and methods for identifying, verifying, and confirming circulating serum-based microRNAs. The microRNAs, referred to as PrognomiRs, can be utilized to differentiate patients suffering from rapidly progressing Parkinson's disease from those with slow progressing forms of the disease. Another notable patent is for "Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis." This invention also focuses on biomarkers and methods for identifying, verifying, and confirming circulating serum-based microRNAs, known as PARKmiRs, which can help distinguish patients suffering from Alzheimer's disease from non-AD patients.

Career Highlights

Ketan Patil is affiliated with St. John's University, where he continues to advance his research and innovations in the medical field. His work has garnered attention for its potential impact on improving diagnostic methods for neurodegenerative diseases.

Collaborations

Ketan collaborates with notable colleagues, including Simon Geir Moller and Guido Werner Alves, who contribute to his research endeavors and innovations.

Conclusion

Ketan Patil's contributions to the field of neurodegenerative disease research through his patents highlight his commitment to advancing medical science. His work has the potential to significantly improve the diagnosis and prognosis of conditions like Parkinson's and Alzheimer's diseases.